| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/RCCM.201509-1759OC |
| P698 | PubMed publication ID | 26492486 |
| P50 | author | Gerdien A Tramper-Stranders | Q42930180 |
| Debby Bogaert | Q56808916 | ||
| Wouter A de Steenhuijsen Piters | Q63922410 | ||
| Anne Wyllie | Q89034544 | ||
| Elisabeth Sanders | Q104749029 | ||
| P2093 | author name string | Cornelis K van der Ent | |
| Sabine M P J Prevaes | |||
| Hettie M Janssens | |||
| Karin M de Winter-de Groot | |||
| Harm A Tiddens | |||
| Mireille van Westreenen | |||
| Raiza Hasrat | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 504-515 | |
| P577 | publication date | 2016-03-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis | |
| P478 | volume | 193 |
| Q38769187 | Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients |
| Q36216240 | Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis. |
| Q46587344 | Alterations of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis. Cystic Fibrosis Transmembrane Conductance Regulator and Antibiotic Effects |
| Q92856709 | Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis |
| Q92456052 | Bacterial and viral respiratory tract microbiota and host characteristics in children with lower respiratory tract infections: a matched case-control study |
| Q52371735 | Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection. |
| Q91983731 | Carriage of a Single Strain of Nontoxigenic Corynebacterium diphtheriae bv. Belfanti (Corynebacterium belfantii) in Four Patients with Cystic Fibrosis |
| Q58803872 | Comparison of the upper and lower airway microbiota in children with chronic lung diseases |
| Q34542383 | Composition and immunological significance of the upper respiratory tract microbiota. |
| Q62589151 | Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases |
| Q89020718 | Culture-Independent Analysis of Pediatric Bronchoalveolar Lavage Specimens |
| Q90726760 | Differences in the lower airway microbiota of infants with and without cystic fibrosis |
| Q38788011 | Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It? |
| Q91813936 | Early respiratory viral infections in infants with cystic fibrosis |
| Q47641823 | Exploring Host-Commensal Interactions in the Respiratory Tract |
| Q40099208 | Impact of nasopharyngeal microbiota on the development of respiratory tract diseases. |
| Q90593660 | Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life: a subanalysis of the MAKI randomised controlled trial |
| Q47653765 | Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children. |
| Q64121707 | Longitudinal development of the airway microbiota in infants with cystic fibrosis |
| Q39309033 | Maturation of the Infant Respiratory Microbiota, Environmental Drivers and Health Consequences: A Prospective Cohort Study |
| Q46244354 | Microbial diversity within the airway microbiome in chronic pediatric lung diseases |
| Q92538704 | Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem |
| Q38936845 | Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease |
| Q64100600 | Nasal Resistome Development in Infants With Cystic Fibrosis in the First Year of Life |
| Q57029609 | Pediatric asthma comprises different phenotypic clusters with unique nasal microbiotas |
| Q89930597 | Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis |
| Q39127064 | The Human Immune Response to Respiratory Syncytial Virus Infection |
| Q38641233 | The airway microbiota in early cystic fibrosis lung disease |
| Q47120731 | The association between anterior nares and nasopharyngeal microbiota in infants hospitalized for bronchiolitis |
| Q36070189 | The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx. |
| Q34553608 | The microbiota of the respiratory tract: gatekeeper to respiratory health |
| Q38867166 | The nasal microbiota in infants with cystic fibrosis in the first year of life: a prospective cohort study |
| Q59356231 | The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens |
| Q38630415 | The temporal dynamics of the tracheal microbiome in tracheostomised patients with and without lower respiratory infections. |
| Q36053575 | Two sampling methods yield distinct microbial signatures in the nasopharynges of asthmatic children |
| Q92262764 | Variation of growth characteristics of pneumococcus with environmental conditions |
Search more.